Linkage honest broker (LHB) services for the national clinical cohort collaborative (N3C)
Ended Awarded
- Contract number
- 75N95025F00064
- Awardee
-
Regenstrief Institute Inc. UEI DJMNLA57HK67
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,950,000
Award facts
- Opportunity
-
- 75N95025Q00192 Solicitation number
- Contract value 100% obligated
- $3,950,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541519 Other Computer Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46202, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a $3,950,000.00 firm fixed price delivery order contract awarded to Regenstrief Institute Inc., a non-profit medical research organization, by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). The contract provides Linkage Honest Broker (LHB) services to support the National Clinical Cohort Collaborative (N3C) Data Enclave, which enables secure access for authorized researchers to integrated and de-identified patient data for COVID-19 research.
This contract was awarded under Regenstrief's $15 million single-award Indefinite Delivery Vehicle (IDV) from NCATS for LHB services. Regenstrief also holds a Multiple Award Schedule contract with the General Services Administration (GSA) with a $1.8 million ceiling, allowing it to offer its specialized health informatics and data services more broadly across federal agencies. The contract does not have a set-aside designation, reflecting Regenstrief's unique capabilities in this area.
Quick answers
Who was awarded contract 75N95025F00064?
75N95025F00064 was awarded to Regenstrief Institute Inc. by National Institute on Drug Abuse (National Institutes of Health) on April 15, 2025.
How much is contract 75N95025F00064 worth?
The government has obligated $3,950,000 on 75N95025F00064.
Which agency awarded contract 75N95025F00064?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025F00064, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95025F00064 an order under another contract?
Yes. 75N95025F00064 is a delivery order under 47QTCA18D00GS, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N95025F00064 competed?
The extent of competition for 75N95025F00064 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award